| Financial Year |
March 31 2023 |
| Monetary Funds |
351,426,384.43 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
140,080,825.88 |
| Advances to Suppliers |
115,828.86 |
| Other Receivables |
1,858,106.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
89,136,711.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,810,738.05 |
| Total Current Assets |
657,357,073.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
368,863,986.39 |
| Under-construction Projects |
1,240,960.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
19,489,867.87 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
428,425.64 |
| Deferred Income Tax Assets |
10,005,106.97 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
402,371,740.21 |
| Total Assets |
1,059,728,813.29 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
59,460,000.00 |
| Accounts Payable |
55,139,874.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,372,836.11 |
| Taxes Payable |
4,221,410.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,660,396.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
276,401.28 |
| Other Current Liabilities |
82,856.02 |
| Sub-Total of Current Liabilities |
147,854,598.14 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,024,478.06 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
37,500,452.91 |
| Total Liabilities |
185,355,051.05 |
| Paid-In Capital(Or Share Stock) |
299,098,170.00 |
| Capital Surplus |
85,147,536.90 |
| Surplus Reserve |
57,629,272.10 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
431,240,349.57 |
| Minority Stockholder's Interest |
553,242.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
873,820,519.63 |
| Owner's Equity（Stockholder's Equity） |
874,373,762.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,059,728,813.29 |
